title: Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee.
abstract: Becaplermin gel is the first topical growth factor to demonstrate therapeutic efficacy in the healing of diabetic wounds. For diabetic patients who have poorly healing ulcers despite good perfusion and a reasonable trial of wound care, this product may be of considerable benefit. It should be tried for a 2-week time period and the results objectively assessed before continuation of therapy.
authors.affiliation: dladin1@hfhs.org
authors.forename: D
authors.initials: D
authors.lastname: Ladin
mesh_terms: D000287:Administration, Topical; D000077214:Becaplermin; D017719:Diabetic Foot / Q000188:drug therapy*; D005782:Gels; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage*; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000008:administration & dosage*; D014945:Wound Healing
chemical_list: D005782:Gels; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin